Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Aug;7(8):835-41.
doi: 10.1023/a:1015960815578.

Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy

Affiliations

Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy

V H Mak et al. Pharm Res. 1990 Aug.

Abstract

A novel application of attenuated total reflectance IR spectroscopy (ATR-IR) was used to monitor the outer several microns of the stratum corneum (SC) and, thereby, demonstrate enhanced percutaneous absorption in vivo in man. 4-Cyanophenol (CP) as a model permeant yielded a unique IR signal, distinct from those of the stratum corneum and the vehicle components. CP was administered for 1, 2, or 3 hr as a 10% (w/v) solution either in propylene glycol or in propylene glycol containing 5% (v/v) oleic acid. The absorbance at 2230 cm-1, which corresponded to C identical to N bond stretching, diminished significantly faster when CP was codelivered with oleic acid. An IR absorbance due primarily to propylene glycol at 1040 cm-1 (C-O stretching) also disappeared more quickly following application of the enhancer-containing solution. In addition, only the formulations with oleic acid induced a higher wavenumber shift in the frequency of the asymmetric C-H bond stretching absorbance. This change indicates increased lipid-chain disorder, the mechanism by which oleic acid is believed to cause enhanced drug transport across the stratum corneum. Therefore, ATR-IR permits one to examine noninvasively the kinetics, extent, and mechanism of percutaneous penetration enhancement in vivo in human subjects.

PubMed Disclaimer

References

    1. Biochemistry. 1988 May 17;27(10):3725-32 - PubMed
    1. J Pharm Sci. 1987 Jan;76(1):25-8 - PubMed
    1. J Invest Dermatol. 1952 Jun;18(6):433-40 - PubMed
    1. Crit Rev Ther Drug Carrier Syst. 1987;3(2):95-122 - PubMed
    1. Biochim Biophys Acta. 1984 Dec 4;779(4):381-401 - PubMed

Publication types

LinkOut - more resources